BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2012
View Archived Issues
Small peptide ALK-3 agonist demonstrates regenerative potential in kidney
Read More
New encapsulated stem cell therapy induces cell death in gliomas
Read More
Notch mRNA signature biomarker monitors effects of PS-1-selective GSI
Read More
New JAK modulators described
Read More
Bayer Schering Pharma develops new vasopressin receptor ligands
Read More
New potential anticancer drugs developed in China
Read More
Novel RAR-related orphan receptor modulators presented
Read More
Novel potential hepatitis therapies reported
Read More
Actelion divulges novel orexin receptor antagonists
Read More
Phase II BTA-798 trial meets primary endpoint
Read More
MorphoSys receives milestone payment from Novartis
Read More
Final phase III Heplisav data are encouraging
Read More
FDA approves line extension for etravirine
Read More
Search for novel triple reuptake inhibitors yields ALB-109780
Read More
Lorus Therapeutics presents preclinical data on small-molecule antimicrobial
Read More
NGM and Daiichi Sankyo to collaborate on novel diabetes therapies
Read More
BioSeek and Merck Serono extend BioMAP collaboration
Read More
Chelsea Therapeutics receives complete response letter regarding Northera
Read More
Allergan seeks approval for line extension of Botox
Read More
Protox advances PRX-302 trial
Read More
Treatment begins in first-in-human CO-1686 study
Read More
DSMB recommends continuation of Menerba study
Read More
Trillium Therapeutics doses first patient in phase I trial of TTI-1612
Read More
Ultragenyx obtains orphan drug designations in Europe for two lead products
Read More
Gruenenthal reports new potassium channel modulators
Read More
JDRF and iCo Therapeutics join to support iDEAL trial
Read More
Depomed receives remaining license fee payment in Acuform collaboration
Read More